| Literature DB >> 32854855 |
Erin O Wissler Gerdes1, Yi Zhu1, B Melanie Weigand1, Utkarsh Tripathi1, Terence C Burns1, Tamar Tchkonia1, James L Kirkland2.
Abstract
Aging is the major predictor for developing multiple neurodegenerative diseases, including Alzheimer's disease (AD) other dementias, and Parkinson's disease (PD). Senescent cells, which can drive aging phenotypes, accumulate at etiological sites of many age-related chronic diseases. These cells are resistant to apoptosis and can cause local and systemic dysfunction. Decreasing senescent cell abundance using senolytic drugs, agents that selectively target these cells, alleviates neurodegenerative diseases in preclinical models. In this review, we consider roles of senescent cells in neurodegenerative diseases and potential implications of senolytic agents as an innovative treatment.Entities:
Keywords: Alzheimer's disease; Cellular senescence; Dasatinib; Fisetin; Navitoclax; Parkinson's disease; Quercetin; Senescence-associated secretory phenotype; Senescent cell anti-apoptotic pathways; Senolytics
Year: 2020 PMID: 32854855 PMCID: PMC7656525 DOI: 10.1016/bs.irn.2020.03.019
Source DB: PubMed Journal: Int Rev Neurobiol ISSN: 0074-7742 Impact factor: 3.230